Navigation Links
Cancer Care of Western New York Becomes First Center in Western New York to Treat Cancer with RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
Date:11/6/2008

Fast form of precise radiotherapy targets tumors quickly and accurately

while minimizing exposure of surrounding healthy tissue

PALO ALTO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- During his annual physical check-up in March, David Kelver's doctor noticed he'd never had his tonsils out, and remarked that the right one looked a bit swollen. The doctor concluded, however, that the problem was minor and would clear up on its own, and sent him home. Several months later, Kelver, a 58-year-old engineer, noticed a lump in his neck. It turned out to be cancer that had started in his tonsil and spread to his lymph nodes.

That was the bad news. Some good news followed, however. Kelver found his way to Dhiren Shah, M.D., radiation oncologist at Cancer Care of Western New York, the first and only treatment center in the area to offer patients treatment using RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE: VAR). RapidArc, a new weapon in the fight against cancer, is a highly-precise form of radiotherapy that targets tumors quickly and accurately while minimizing exposure of surrounding healthy tissue.

"David had to choose between radical surgery or chemotherapy with radiation," said Dr. Shah. "He chose the chemo/radiation combination because it offers the same potential cure rate as surgery while being less invasive and disfiguring."

RapidArc technology makes it possible for Dr. Shah to deliver a precise image-guided IMRT treatment in two minutes or less, which is two to eight times faster than was previously possible with conventional IMRT. "The treatment itself is only about 40-60 seconds; the set-up prior to treatment takes longer," Kelver said. "I never had conventional radiation but I
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents
2. Bradmer sponsors physician panel to raise awareness of brain cancer treatments
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
4. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
5. Data Presented at Cancer Molecular Markers Meeting Suggests Clinical Benefit for Integrating New Molecular Tests
6. Breast Cancer Patients Take DNA Test to Determine Best Treatment
7. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
8. Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
9. Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer
10. AstraZeneca and M. D. Anderson Renew Cancer Research Collaboration
11. Japanese Cancer Association and Debiopharm Honour Japanese Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... ANGELES , Feb. 26, 2015 Tauriga ... life sciences company with interests in the natural wellness ... technology, announced today that its products will be featured ... Roth Capital Partners, 27 th Annual Growth Stock ... Carlton, located at 1 Ritz Carlton Drive, ...
(Date:2/26/2015)... PHILADELPHIA , Feb. 26, 2015  Spark Therapeutics (NASDAQ: ... its management team will participate in the Cowen and ... at 9:40 a.m., Eastern, at the Boston Marriott Copley ... a Spark Therapeutics presentation from the Cowen conference, please ... Events" section of the Spark Therapeutics website at ...
(Date:2/26/2015)... , Feb. 26, 2015 Caris Life ... at the 2015 Genitourinary Cancers Symposium in ... clinical utility of tumor profiling. Both studies utilized ... profiling service, to identify biomarkers that shed light ... and small cell bladder cancer (SCBC). ...
(Date:2/25/2015)... , Feb. 25, 2015 truBrain ... is featured in this week,s Power Pitch segment ... to discuss the company,s traction and growth strategy, ... the crowd funding site CircleUp. The ... that are validated by neurotechnology, while also discussing ...
Breaking Biology Technology:SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 2SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 3SEC Compliance Featuring Products From Tauriga Sciences, Inc. at ROTH Capital Conference 4Spark Therapeutics to Participate in the 35th Annual Cowen and Company Health Care Conference 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 3Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 4Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 5CNBC's Power Lunch Features Neurotechnology Start-up truBrain 2
... CRY ), a,biomaterials, medical device and tissue processing company, ... Annual Piper Jaffray Health,Care Conference at The New York Palace ... Anderson, president and chief executive officer of CryoLife,Inc., will provide ... 2:30 p.m. Eastern Time. , ...
... The Global Probiotics Council,(GPC), a committee formed ... the availability of two grants for the second ... Each Young,Investigator Grant will provide $50,000 over one ... role of probiotics and gastrointestinal microbiota in health,and ...
... Queen,s University Belfast is to become the United Kingdom,s ... ,cyber-attacks, after a funding boost from the Engineering and ... the EPSRC will help fund a new Innovation and ... (CSIT) - which will be based at Queen,s Institute ...
Cached Biology Technology:CryoLife to Present at 20th Annual Piper Jaffray Health Care Conference 2New Young Investigator Grants for Probiotics Research Announced 2New Young Investigator Grants for Probiotics Research Announced 3New Young Investigator Grants for Probiotics Research Announced 4Queen's secures £25M for UK's cyber safety 2
(Date:2/24/2015)... 24, 2015 Research and Markets ... the "Global 2D Gesture Recognition Market 2015-2019" ... The analysts forecast the Global 2D Gesture Recognition ... over the period 2014-2019 The increased ... is one of the major trends in the ...
(Date:2/12/2015)... , Feb. 12, 2015   MedNet Solutions ... in clinical study management systems, has recently bolstered ... further distinguishing iMedNet as ... Organizations (CROs) and healthcare consultants.  Building on the ... customer referrals and numerous co-marketing opportunities), MedNet,s new ...
(Date:2/5/2015)... PARK, North Carolina , 5. Februar ... 35. Jahr als spezialisiertes Logistikunternehmen und hat ... als einzige klinische Logistikfirma (Clinical Logistics Organization ... Kernbotschaft der neuen Kampagne lautet First ... Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3
... first time, scientists have shown that amniotic fluid (the ... new source of stem cells for therapeutic applications. The ... Blood , the official journal of the American ... other scientists, our research team wondered whether stem cells ...
... that its latest journal, Disease Models & Mechanisms ... MEDLINE. MEDLINE (http://www.pubmed.gov) is the premier bibliographic database of ... National Institutes of Health (NIH), MEDLINE contains over 16 million ... DMM has been recommended for inclusion by ...
... Md. (Mar. 31, 2009) Octogenarian women were unable to ... targeted at strengthening the thigh muscle, according to a ... . The results are surprising because previous studies have ... for people who are into their 70s. An increase ...
Cached Biology News:Amniotic fluid may provide new source of stem cells for future therapies 2Amniotic fluid may provide new source of stem cells for future therapies 3Disease Models & Mechanisms -- selected for indexing in Medline 2As good as it gets: Octogenarian muscles don't get stronger with exercise 2As good as it gets: Octogenarian muscles don't get stronger with exercise 3
Homo sapiens olfactomedin 1, transcript variant 3...
... agarose-digesting enzyme isolated from Pseudomonas atlantica. ... in agarose producing carbohydrate molecules that ... carbohydrate molecules will not interfere with ... Gelzyme enzyme can be used for ...
... the cellular components necessary for protein synthesis ... termination factors) but has not been treated ... primarily for the isolation of these components ... globin mRNA. Untreated Lysate is prepared from ...
...
Biology Products: